3RD GENERATION CEPHALOSPORINS - SAFETY PROFILES AFTER 10 YEARS OF CLINICAL USE

被引:35
作者
NEU, HC [1 ]
机构
[1] COLUMBIA UNIV COLL PHYS & SURG,DEPT PHARMACOL,NEW YORK,NY 10032
关键词
D O I
10.1002/j.1552-4604.1990.tb03476.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Compared with aminoglycosides, chloramphenicol, sulfonamides, tetracyclines, and even penicillins, the cephalosporins represent a remarkably safe class of antibiotics. Among the cephalosporins, the extended spectrum, third generation agents developed generally produce few side effects and appear to be less allergenic than the penicillins. Nephrotoxicity has not been a problem at recommended doses. Some third generation agents can cause hypoprothrombinemia if not administered with vitamin K, and disulfiram-like reactions occur with some agents because of the presence of a thiomethyl tetruzole moiety affixed to the cephem nucleus. There is a greater incidence of diarrhea associated with the agents excreted through a primarily biliary route, and this may contribute to the selection of drug resistant bacteria. Some agents are less active against staphylococci and their use may result in an increased incidence of superinfection or overgrowth of enterococci. If attention is given to the potential for adverse effects, many of these problems can be avoided and the third generation cephalosporins can be used safely in hospitals, nursing homes, and home care settings
引用
收藏
页码:396 / 403
页数:8
相关论文
共 58 条
[1]  
AGNELLI G, 1986, ANTIMICROB AGENTS CH, V6, P1108
[2]   CEFTRIAXONE - RENAL AND BILIARY-EXCRETION AND EFFECT ON THE COLON MICROFLORA [J].
ARVIDSSON, A ;
ALVAN, G ;
ANGELIN, B ;
BORGA, O ;
NORD, CE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1982, 10 (03) :207-215
[3]   CEFOPERAZONE IN THE TREATMENT OF SEVERE OR COMPLICATED INFECTIONS [J].
BAILEY, RR ;
PEDDIE, B ;
BLAKE, E ;
BISHOP, V ;
REDDY, J .
DRUGS, 1981, 22 :76-86
[4]  
BAIRD IM, 1983, REV INFECT DIS S, V1, P165
[5]   PROSPECTIVE COMPARATIVE TRIAL OF CEFTRIAXONE VS CONVENTIONAL THERAPY FOR TREATMENT OF BACTERIAL-MENINGITIS IN CHILDREN [J].
BARSON, WJ ;
MILLER, MA ;
BRADY, MT ;
POWELL, DA .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1985, 4 (04) :362-368
[6]  
BAUMGARTNER JD, 1984, AM J MED, V77, P54
[7]  
Beutler E, 1983, METABOLIC BASIS INHE, P1629
[8]   EFFECT OF BROAD-SPECTRUM CEPHALOSPORINS ON THE MICROBIAL-FLORA OF RECIPIENTS [J].
BODEY, GP ;
FAINSTEIN, V ;
GARCIA, I ;
ROSENBAUM, B ;
WONG, Y .
JOURNAL OF INFECTIOUS DISEASES, 1983, 148 (05) :892-897
[9]   INTESTINAL SIDE-EFFECTS OF CEFOPERAZONE [J].
CARLBERG, H ;
ALESTIG, K ;
NORD, CE ;
TROLLFORS, B .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1982, 10 (06) :483-487
[10]   A COMPARISON OF THE EFFECTS OF MEZLOCILLIN AND CARBENICILLIN ON HEMOSTASIS IN VOLUNTEERS [J].
COPELAN, EA ;
KUSUMI, RK ;
MILLER, L ;
FASS, RJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 11 :43-49